Glucagon-like peptide 1 receptor agonists in substance use disorders: A systematic review of ClinicalTrials.Gov

Puntos clave

• GLP-1 receptor agonists may impact treatment outcomes for substance use disorders, enhancing recovery processes.
• The analysis reveals significant data from clinical trials focusing on behavioral and pharmacological interventions.
• Systematic review across multiple studies demonstrates the potential benefits of using GLP-1 receptor agonists.
• Research highlights a growing interest in the application of GLP-1 receptor modulation in addiction treatment.